INBX - Company ID 0001739614
The table below shows Inhibrx, Inc.'s balance sheet line items across its last 4 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Cash & equivalents | $277.92M | $273.87M | $131.30M | $128.66M |
| Short-term investments | - | - | - | - |
| Receivables | - | $243.00K | $373.00K | $82.00K |
| Inventory | - | - | - | - |
| Total current assets | $295.36M | $280.49M | $139.11M | $132.17M |
| Property, plant & equipment | $6.42M | $2.50M | $3.15M | $3.49M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Goodwill | - | - | - | - |
| Total assets | $307.89M | $290.88M | $150.45M | $143.74M |
| Accounts payable | $10.95M | $8.33M | $9.13M | $13.46M |
| Total current liabilities | $56.31M | $27.58M | $22.45M | $31.40M |
| Long-term debt | - | - | - | - |
| Total liabilities | $264.39M | $232.82M | $98.07M | $68.27M |
| Retained earnings | -$613.73M | -$372.37M | -$227.15M | -$145.38M |
| Total equity | $43.50M | $58.06M | $52.38M | $75.47M |